These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33288543)
1. Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts. Krishna V; Yin X; Song Q; Walsh A; Pocalyko D; Bachman K; Anderson I; Madakamutil L; Nagpal S J Immunol; 2021 Jan; 206(2):422-431. PubMed ID: 33288543 [TBL] [Abstract][Full Text] [Related]
2. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes. Xiao Y; Liang L; Huang M; Qiu Q; Zeng S; Shi M; Zou Y; Ye Y; Yang X; Xu H Rheumatology (Oxford); 2016 Jan; 55(1):173-84. PubMed ID: 26324948 [TBL] [Abstract][Full Text] [Related]
7. BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell. Deeney JT; Belkina AC; Shirihai OS; Corkey BE; Denis GV PLoS One; 2016; 11(3):e0151329. PubMed ID: 27008626 [TBL] [Abstract][Full Text] [Related]
8. Targeting BRD4 to attenuate RANKL-induced osteoclast activation and bone erosion in rheumatoid arthritis. Wang C; Zhang H; Wang X; Ma X; Zhang J; Zhang Y Mol Cell Biochem; 2024 Aug; ():. PubMed ID: 39110281 [TBL] [Abstract][Full Text] [Related]
9. Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function. Cribbs AP; Filippakopoulos P; Philpott M; Wells G; Penn H; Oerum H; Valge-Archer V; Feldmann M; Oppermann U Front Immunol; 2021; 12():626255. PubMed ID: 33717143 [TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets. Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1. Decker TM; Kluge M; Krebs S; Shah N; Blum H; Friedel CC; Eick D Sci Rep; 2017 May; 7(1):1684. PubMed ID: 28490802 [TBL] [Abstract][Full Text] [Related]
12. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity. Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503 [TBL] [Abstract][Full Text] [Related]
13. Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1. Mumby S; Perros F; Grynblat J; Manaud G; Papi A; Casolari P; Caramori G; Humbert M; John Wort S; Adcock IM Respir Res; 2023 Jul; 24(1):193. PubMed ID: 37516840 [TBL] [Abstract][Full Text] [Related]
14. Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2. Doherty J; Mandati V; González Rodriguez MA; Troutman S; Shepard A; Harbaugh D; Brody R; Miller DC; Kareta MS; Kissil JL Neurooncol Adv; 2022; 4(1):vdac072. PubMed ID: 35855490 [TBL] [Abstract][Full Text] [Related]
15. BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes. Wu S; Jiang Y; Hong Y; Chu X; Zhang Z; Tao Y; Fan Z; Bai Z; Li X; Chen Y; Li Z; Ding X; Lv H; Du X; Lim SL; Zhang Y; Huang S; Lu J; Pan J; Hu S Cancer Cell Int; 2021 Apr; 21(1):230. PubMed ID: 33888130 [TBL] [Abstract][Full Text] [Related]
16. BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling. Zhou S; Zhang S; Wang L; Huang S; Yuan Y; Yang J; Wang H; Li X; Wang P; Zhou L; Yang J; Xu Y; Gao H; Zhang Y; Lv Y; Zou X Oncogenesis; 2020 Mar; 9(3):33. PubMed ID: 32157097 [TBL] [Abstract][Full Text] [Related]
17. BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial Fibroblasts. Seifritz T; Brunner M; Camarillo Retamosa E; Maciukiewicz M; Krošel M; Moser L; Züllig T; Tomšič M; Distler O; Ospelt C; Klein K Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137409 [TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Targeting of BET Proteins in Cancer. French CA Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123 [TBL] [Abstract][Full Text] [Related]
19. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
20. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]